Literature DB >> 15789367

Statins and hepatotoxicity: focus on patients with fatty liver.

Naga Chalasani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15789367     DOI： 10.1002/hep.20671

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  65 in total

1.  Treatment options for nonalcoholic Fatty liver disease.

Authors:  Shivakumar Chitturi
Journal:  Therap Adv Gastroenterol       Date:  2008-11       Impact factor: 4.409

2.  Hepatic adverse drug reactions: a case/non-case study in Italy.

Authors:  Domenico Motola; Antonio Vargiu; Roberto Leone; Alfredo Cocci; Francesco Salvo; Barbara Ros; Ilaria Meneghelli; Mauro Venegoni; Paola Maria Cutroneo; Alberto Vaccheri; Gianpaolo Velo; Nicola Montanaro
Journal:  Eur J Clin Pharmacol       Date:  2006-11-22       Impact factor: 2.953

3.  Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

Authors:  Ruth McPherson; Jiri Frohlich; George Fodor; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

4.  Statins and monitoring of liver function tests.

Authors:  Karam Kostner; Laurence G Howes
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Clinical perspective: statins and the liver--harmful or helpful?

Authors:  James H Lewis
Journal:  Dig Dis Sci       Date:  2012-05-12       Impact factor: 3.199

Review 6.  Idiosyncratic drug-induced liver injury: a clinical update.

Authors:  Haripriya Maddur; Naga Chalasani
Journal:  Curr Gastroenterol Rep       Date:  2011-02

7.  [Non-alcoholic hepatic steatosis. An update].

Authors:  Llorenç Caballería Rovira; Pere Torán Montserrat; María Antonia Auladell Llorens; Guillem Pera Blanco
Journal:  Aten Primaria       Date:  2008-08       Impact factor: 1.137

Review 8.  The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease.

Authors:  Yue Zhao; Tian-Yu Wu; Meng-Fei Zhao; Chao-Jun Li
Journal:  J Biol Chem       Date:  2020-03-05       Impact factor: 5.157

9.  NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.

Authors:  Sombat Treeprasertsuk; Einar Björnsson; Felicity Enders; Sompongse Suwanwalaikorn; Keith D Lindor
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

Review 10.  Pleiotropic effects of statins in the diseases of the liver.

Authors:  Martin Janicko; Sylvia Drazilova; Daniel Pella; Jan Fedacko; Peter Jarcuska
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.